New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study
source: pixabay.com

New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study

Data has recently been announced from a study investigating the efficacy of a new therapy called Alpelisib, for the treatment of PIK3CA-related overgrowth spectrum (PROS). The study was called EPIK-P1.…

Continue Reading New Therapy Shows Promise For PIK3CA-Related Overgrowth Spectrum in Retrospective Study

CLOVES Syndrome Community’s CLOVES Family Conference

  • Post author:
  • Post category:

The 2019 CLOVES Family Conference Boston, Massachusetts Are you a CLOVES syndrome patient? Well don’t miss this important patient event. At this conference, CLOVES syndrome patients and their families will…

Continue Reading CLOVES Syndrome Community’s CLOVES Family Conference